Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC)
- 30 September 2004
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 45 (3) , 373-380
- https://doi.org/10.1016/j.lungcan.2004.01.023
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized TrialJNCI Journal of the National Cancer Institute, 2003
- Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 2001
- Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?Lung Cancer, 2000
- Where to go with new expensive treatments in NSCLCBritish Journal of Cancer, 1998
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Chemotherapy and Survival in Non-Small Cell Lung CancerChest, 1994
- Chemotherapy and Survival in Non-Small Cell Lung CancerChest, 1991
- Reporting results of cancer treatmentCancer, 1981
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960